Drugmaker cites lower contribution from key US products, higher R&D investments and rising operating costs as Q4 FY26 profit declines sharply
Source :- Companies Read More
Cipla Q4 profit plunges 55% to ₹554.6 cr amid US drag, higher R&D spend
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
